| (Values in U.S. Thousands) | Jun, 2025 | Dec, 2024 | Jun, 2024 | Dec, 2023 | Jun, 2023 |
| Sales | 0 | 0 | 0 | 0 | 0 |
| Sales Growth | unch | unch | unch | unch | unch |
| Net Income | 0 | 0 | 0 | 0 | 0 |
| Net Income Growth | unch | unch | unch | unch | unch |
Itaconix Plc (ITX.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Itaconix PLC is developing and producing bio-based polymers from itaconic acid. The company products are used in the safety of home care, personal care, and industrial sectors. Geographically, it derives the majority of its revenue from North America and also has a presence in Europe. The Company has three business segments which include Performance Ingredients develops, produces, and sells proprietary specialty polymers that are used as functional ingredients to meet customers' needs in cleaning, beauty, and hygiene products. Formulation Solutions provides technical services and ingredient supplies for formulated products developed for customers based on Performance Ingredients. Core Operations include development expense, general and administrative expense, professional fees.
Fiscal Year End Date: 12/31